Showing 1 - 17 results of 17 for search '"typhoid fever"', query time: 0.08s Refine Results
  1. 1

    How can the typhoid fever surveillance in Africa and the severe typhoid fever in Africa programs contribute to the introduction of typhoid conjugate vaccines? by Jeon, HJ, Im, J, Haselbeck, A, Holm, M, Rakotozandrindrainy, R, Bassiahi, AS, Panzner, U, Mogeni, OD, Seo, HJ, Lunguya, O, Jacobs, J, Okeke, IN, Terferi, M, Owusu-Dabo, E, Dougan, G, Carey, M, Steele, AD, Kim, JH, Clemens, JD, Andrews, JR, Park, SE, Baker, S, Marks, F

    Published 2019
    “…Data from the Severe Typhoid Fever in Africa (SETA) program were used to contribute to TCV introduction decision-making processes, exemplified for Ghana and Madagascar. …”
    Journal article
  2. 2
  3. 3

    Reproducible diagnostic metabolites in plasma from typhoid fever patients in Asia and Africa. by Näsström, E, Parry, C, Thieu, N, Maude, R, de Jong, H, Fukushima, M, Rzhepishevska, O, Marks, F, Panzner, U, Im, J, Jeon, H, Park, S, Chaudhury, Z, Ghose, A, Samad, R, Van, T, Johansson, A, Dondorp, A, Thwaites, G, Faiz, A, Antti, H, Baker, S

    Published 2017
    “…Here, we performed mass spectrometry on plasma from Bangladeshi and Senegalese patients with culture confirmed typhoid fever, clinically suspected typhoid, and other febrile diseases including malaria. …”
    Journal article
  4. 4

    The monitoring and evaluation of a multicountry surveillance study, the Severe Typhoid Fever in Africa Program by Mogeni, OD, Cruz Espinoza, LM, Im, J, Panzner, U, Toy, T, Pak, GD, Haselbeck, A, Ramani, E, Schütt-Gerowitt, H, Jacobs, J, Metila, OL, Adewusi, OJ, Okeke, IN, Ogunleye, VI, Owusu-Dabo, E, Rakotozandrindrainy, R, Soura, AB, Teferi, M, Roy, KC, Macwright, W, Breiman, RF, Kim, JH, Mogasale, V, Baker, S, Park, SE, Marks, F

    Published 2019
    “…Here, we describe the monitoring and evaluation procedures created for the multicountry Severe Typhoid Fever in Africa (SETA) study.</p> <p><strong>Methods</strong> Elements from the US Food and Drug Administration (FDA) and European Centre for Disease Prevention and Control (ECDC) recommendations on monitoring clinical trials and data quality, respectively were applied in the development of the SETA monitoring plan. …”
    Journal article
  5. 5
  6. 6
  7. 7
  8. 8

    Occurrence of typhoid fever complications and their relation to duration of illness preceding hospitalization: A systematic literature review and meta-analysis by Cruz Espinoza, LM, McCreedy, E, Holm, M, Im, J, Mogeni, OD, Parajulee, P, Panzner, U, Park, SE, Toy, T, Haselbeck, A, Seo, HJ, Jeon, HJ, Kim, J-H, Kwon, SY, Kim, JH, Parry, CM, Marks, F

    Published 2019
    “…<strong>Background</strong> Complications from typhoid fever disease have been estimated to occur in 10%–15% of hospitalized patients, with evidence of a higher risk in children and when delaying the implementation of effective antimicrobial treatment. …”
    Journal article
  9. 9

    Acute febrile illness among children in Butajira, south–central Ethiopia during the Typhoid Fever Surveillance in Africa Program by Teferi, M, Desta, M, Yeshitela, B, Beyene, T, Cruz Espinoza, LM, Im, J, Jeon, HJ, Kim, J-H, Konings, F, Kwon, SY, Pak, GD, Park, JK, Park, SE, Yedenekachew, M, Kim, J, Baker, S, Sir, WS, Marks, F, Aseffa, A, Panzner, U

    Published 2019
    “…We investigated acute febrile illness in children aged ≤15 years enrolled at healthcare facilities in Butajira, Ethiopia, during January 2012 to January 2014 for the Typhoid Fever Surveillance in Africa Program.</p> <p><strong>Methods</strong> Blood culture, malaria microscopy, and blood analyses followed by microbiological, biochemical, and antimicrobial susceptibility testing of isolates were performed. …”
    Journal article
  10. 10
  11. 11
  12. 12

    Aspects of disease burden and risk factors for bacterial disease in low- and middle-income countries by Im, J

    Published 2021
    “…Secondly, I developed a clinical definition for typhoid fever that satisfied the criteria of being predictive of culture-confirmed typhoid fever and being protected against by an effective typhoid vaccine. …”
    Thesis
  13. 13
  14. 14
  15. 15

    Determining the best immunization strategy for protecting African children against invasive Salmonella disease by Jeon, HJ, Pak, GD, Im, J, Owusu-Dabo, E, Adu-Sarkodie, Y, Sow, A, Bassiahi, AS, Gasmelseed, N, Keddy, KH, Bjerregaard-Andersen, M, Konings, F, Aseffa, A, Crump, JA, Chon, Y, Breiman, RF, Park, SE, Espinoza, LM, Seo, HJ, May, J, Meyer, CG, Andrews, JR, Panzner, U, Von Kalckreuth, V, Wierzba, TF, Rakotozandrindrainy, R, Dougan, G, Levine, MM, Hombach, J, Kim, JH, Clemens, JD, Baker, S, Marks, F

    Published 2018
    “…<strong>Background</strong> The World Health Organization recently prequalified a typhoid conjugate vaccine (TCV), recommending its use in persons ≥6 months to 45 years residing in typhoid fever (TF)–endemic areas. We now need to consider how TCVs can have the greatest impact in the most vulnerable populations. …”
    Journal article
  16. 16

    The global burden and epidemiology of invasive non-typhoidal Salmonella infections by Balasubramanian, R, Im, J, Lee, J, Jeon, H, Mogeni, O, Kim, J, Rakotozandrindrainy, R, Baker, S, Marks, F

    Published 2018
    “…The accessibility of whole genome sequencing has allowed for genetic characterization of pathogens, shedding light on its evolutionary history and sounding alerts for its future progression. iNTS disease is observed to be a particular threat in sub-Saharan Africa, with a case fatality rate greatly exceeding that of typhoid fever, and commonly affecting infants, young children and immunocompromised adults. …”
    Journal article
  17. 17